Arcutis Announces Second Quarter 2026 Financial Results and Provides Business Update
Arcutis reported Q2 net product revenue of $129.9 million, up 59% year-over-year, driven by strong demand for the ZORYVE franchise and improved pricing. The company achieved profitability with net income of $15.0 million, or $0.11 per share, and raised full-year 2026 sales guidance to $525 million–$540 million.
Key figures
- Eps
- 0.11
- Revenue
- $129.9 million
- Guidance
- Net product sales $525 million–$540 million, raised from $480 million–$495 million
- Revenue Yoy
- 59%
- Net income
- 15000000
- Operating cash flow
- 12600000
- Zoryve foam 03 revenue
- $67.4 million
- Zoryve cream 03 revenue
- $35.3 million
- Zoryve cream 015 revenue
- $24.2 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.